col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Elsevier: Transfusion Clinique et Biologique
  original article Date Title Authors   All Authors
1 [GO] 2021―Dec―29 Diminution significative des taux de transfusion pendant la pandémie de COVID-19 dans le nord-est de l’Iran Samaneh Boroumand-Noughabi, Atefe Rahmati, Negar Morovatdar, Mohammadreza Keramati
2 [GO] 2021―Dec―29 SARS-CoV-2 variants in immunocompromised COVID-19 patients: The underlying causes and the way forward Naveen Bansal, Manish Raturi, Yashik Bansal
3 [GO] 2021―Dec―16 Seroprevalence of SARS-CoV-2 among blood donors: A practical serosurveillance tool for COVID-19 Naveen Bansal, Manish Raturi, Yashik Bansal
4 [GO] 2021―Dec―11 COVID-19 Convalescent plasma use in the oncology and geriatric patients: Ethical aspects in transfusion medicine Naveen Bansal, Manish Raturi, Yashik Bansal
5 [GO] 2021―Nov―23 Organisation de la collecte, préparation, qualification et mise à disposition de plasmas issus de donneurs convalescents de la COVID-19 Thibaut Bocquet, Hervé Meinrad, Cathy Bliem, Pascal Morel
6 [GO] 2021―Nov―23 Le coombs direct, phénomène « transmissible » chez les patients COVID-19 Alice Brochier, Véronique Deneys
7 [GO] 2021―Nov―23 Suivi cartographique des prélèvements de produits sanguins et de l’épidémie de la COVID-19 Philippe-Antoine Halbout, Martin Lucas, Hervé Meinrad
8 [GO] 2021―Nov―23 Groupe sanguin ABO et COVID-19 Rania Hadj Taieb, Sonia Mahjoub, Nouha Ben Amara, Aya Chakroun, Héla Baccouche, Neila Ben Romdhane
9 [GO] 2021―Nov―23 L’impact de la pandémie COVID-19 sur la continuité des soins transfusionnels pour les patients thalassémiques : à propos d’un cas Sabah Bouhou, Mohammed Benajiba, Azlarab Masrar
10 [GO] 2021―Nov―23 Gestion de l’impact de la pandémie COVID-19 sur le système transfusionnel: expérience du Centre national marocain de transfusion sanguine et d’hématologie (CNTSH) Sabah Bouhou, Khadija Lahjouji, Mohammed Benajiba, Azlarab Masrar
11 [GO] 2021―Nov―23 Profils d’anticorps dans le plasma de convalescent COVID-19 traité pour traitement de réduction des agents pathogènes par Amotosalen/UVA Laurence Corash, Jean-Marc Payrat, Anil Bagri
12 [GO] 2021―Nov―23 PFC Covid-19, un an d’hémovigilance à Saint-Antoine AP-HP Virginie De La Taille, Sabine Guessant
13 [GO] 2021―Nov―23 Groupe sanguin ABO et sévérité de la COVID-19 : étude monocentrique Imene Dimassi, Sonia Mahjoub, Rahma Cherni, Héla Baccouche, Aya Chakroun, Neila Ben Romdhane
14 [GO] 2021―Nov―23 Délai de don de sang après vaccination COVID-19 : l’état actuel des recommandations Sabah Bouhou, Khadija Lahjouji, Azlarab Masrar
15 [GO] 2021―Nov―23 Plasma de convalescents du COVID-19 : premiers résultats en AURA Marion François, Michel Raba, Caroline Baud
16 [GO] 2021―Nov―23 Bilan des FIPDs COVID-19 déclarées sur e-FIT Sixtine Drougard, Karim Boudjedir, Imad Sandid, Muriel Fromage, Caroline Matko, Isabelle Sainte-Marie, Isabelle Yoldjian
17 [GO] 2021―Nov―23 Faisabilité de la transfusion de plasma de donneurs convalescents pour COVID-19 en réanimation Fabrice Camou, Mathilde Beguet-Yacine, Marie-Edith Lafon, Xavier Lafarge, Pantxika Bellecave, Fabrice Bonnet, Nahema Issa
18 [GO] 2021―Nov―23 Impact du COVID-19 et du confinement sur la transfusion Xavier Delabranche, Daniel Kientz, Charles Tacquard, Françoise Bertrand, Anne-Claude Roche, Pierre Tran Ba Loc, et al. (+8)
19 [GO] 2021―Nov―23 Coombs direct positif chez les patients COVID-19 et transfusion : arbre décisionnel Julien Cabo
20 [GO] 2021―Nov―23 Auto-anticorps anti-interférons de type I et COVID-19 sévère Paul Bastard, Adrian Gervais, Tom Le Voyer, Jérémie Rosain, Quentin Philippot, Jean-Laurent Casanova, et al. (+4)
21 [GO] 2021―Nov―23 Protocole d’usage thérapeutique du plasma de convalescent de COVID-19-Suivi Anne-Marie Fillet, Virginie Ferrera-Tourenc, Marion François, Anne François, Valérie Porra, Isabelle Dettori, et al. (+10)
22 [GO] 2021―Nov―23 AHAI révélant une infection par le coronavirus SARS-CoV-2 chez un nourrisson Manel Hsairi, Ameni Khemekhem, Taicir Rekik, Ghada Baccar, Hela Menif, Abdelamjid Mahfoudh, Ikram Ben Amor
23 [GO] 2021―Nov―23 Gestion du don de sang lors de la pandémie SARS-CoV-2 Taicr Rekik, Hela Menif, Ameni Khemekhem, Narjes Mezghani, Jalel Gargouri, Nour Louati, Ikram Ben Amor
24 [GO] 2021―Nov―23 Le risque de transmission du SARS-CoV-2 par le sang et les produits sanguins : l’état actuel des connaissances Sabah Bouhou, Mohammed Benajiba, Azlarab Masrar
25 [GO] 2021―Nov―23 Information post-don (IPD) SARS-CoV-2 avec transfusion de concentré de globules rouges (CGR) chez un receveur immunodéprimé Philippe Cabre, Emmanuelle Boulanger, Dorine Seuront-Scheffbuch
26 [GO] 2021―Nov―23 Quelle place pour les tests sérologiques SARS-CoV-2 chez la population des donneurs de sang ? Sabah Bouhou, Imane Douabi, Khadija Lahjouji, Mohammed Benajiba, Azlarab Masrar
27 [GO] 2021―Nov―23 DGVRetroDon : contribution à l’évaluation du risque de transmission du SARS-CoV-2 par transfusion par un dépistage de l’ARN viral plasmatique dans des dons de sang en France Sophie Le Cam, Céline Ricard, Céline Narboux, Valérie Barlet, Claude Maugard, Pierre Cappy, et al. (+5)
28 [GO] 2021―Nov―23 Place de l’hémovigilance dans le contexte de la pandémie Sars-Cov2 Ilham Lemssahli, Khadija Lahjouji, Sabah Bouhou
29 [GO] 2021―Oct―13 SARS COV-2- IgG antibodies in blood donors in pandemic - a game changer for policy makers Smita Mahapatra
30 [GO] 2021―Aug―28 Failure of plasma therapy in Covid-19 Pathum Sookaromdee, Viroj Wiwanitkit
31 [GO] 2021―Aug―16 Efficient inactivation of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in human apheresis platelet concentrates with amotosalen and ultraviolet A light Salwa I Hindawi, Sherif A El-Kafrawy, Ahmed M Hassan, Maha A. Badawi, Maiman M. Bayoumi, Ahmad A. Almalki, et al. (+7)
32 [GO] 2021―Aug―12 Has plasma therapy failed in Covid-19 or we have failed in using it properly in India? -lessons learned through the pandemic Suvro Sankha Datta, Ritam Chakrabarty
33 [GO] 2021―Aug―03 Convalescent Covid-19 plasma: Back-to-basics and ethics, and next steps O. Garraud, T. Burnouf
34 [GO] 2021―Jul―29 Impact of pathogen reduction technology on neutralizing antibody titer in COVID-19 convalescent plasma Massimo Franchini, Fausto Baldanti, Elena Percivalle, Alessandro Ferrari, Pietro Biasi, Giancarlo Maria Liumbruno, Claudia Glingani
35 [GO] 2021―Jul―22 Seroprevalence of SARS-CoV-2 among potential convalescent plasma donors and analysis of their deferral pattern: Experience from tertiary care hospital in western India Romesh Jain, M.V. Mallya, Sangeeta Amoncar, Sachin Palyekar, Harshad Popat Adsul, Rakesh Kumar, Sumit Chawla
36 [GO] 2021―Jul―01 SARS-CoV-2 infection in patients with β-thalassemia: the French experience Estelle Jean-Mignard, Gonzalo De Luna, Laurent Pascal, Imane Agouti, Isabelle Thuret
37 [GO] 2021―Jun―24 A novel scoring system for selecting the target patients of COVID-19 convalescent plasma therapy: A hypothesis Naveen Bansal, Manish Raturi, Yashik Bansal, Pushpendra Singh
38 [GO] 2021―Jun―15 COVID-19 convalescent plasma therapy for immunodeficient patients - weighing up risks and benefits Tomislav Vuk, Ana Hećimović, Irena Jukić, Sanda Ravlić, Tihana Kurtović, Dina Rnjak, Beata Halassy
39 [GO] 2021―Jun―15 La pénurie d'approvisionnement en sang induite par le Covid-19: Perspective d'un dépôt de sang tunisien Emna Hammami, Mariem Hadhri, Sarra Fekih Salem, Fatma Ben Lakhal, Wijden El Borgi, Emna Gouider
40 [GO] 2021―Jun―07 Positive Direct Antiglobulin Test in COVID-19 patients: decision-making process Julien Cabo, Alice Brochier, Pascale Saussoy, Marie-Astrid van Dievoet, Lena Capirchio, Bénédicte Delire, Véronique Deneys
41 [GO] 2021―Jun―05 Covid-19 convalescent plasma therapy: Analyzing factors that led to its failure in India Naveen Bansal, Manish Raturi, Yashik Bansal
42 [GO] 2021―May―29 Covid-19 convalescent plasma and SARS-CoV-2 viral variants Beuy Joob, Viroj Wiwanitkit
43 [GO] 2021―May―29 COVID-19 convalescent plasma therapy and immunodeficiency Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
44 [GO] 2021―May―29 Blood Donation during COVID-19 Vaccination drive - The Need for Concern Tarun Kumar Suvvari, LV Simhachalam Kutikuppala, Naga Alekhya Garikipati, Sai Venkata Kalyani Ponnaganti, Venkata Ramana Kandi
45 [GO] 2021―May―19 Convalescent Plasma Therapy in the management of COVID-19 patients-The newer dimensions S. Mahapatra, R. Rattan, C.B.K. Mohanty
46 [GO] 2021―May―07 Locally harvested Covid-19 convalescent plasma could probably help combat the geographically determined SARS-CoV-2 viral variants Manish Raturi, Anuradha Kusum, Mansi Kala, Garima Mittal, Anita Sharma, Naveen Bansal
47 [GO] 2021―May―07 COVID-19 vaccination: The impact on the selection criteria of the convalescent plasma donors Naveen Bansal, Manish Raturi, Yashik Bansal
48 [GO] 2021―Apr―24 COVID-19 convalescent plasma as long-term therapy in immunodeficient patients? D. Rnjak, S. Ravlić, A.-M. Šola, B. Halassy, J. Šemnički, M. Šuperba, et al. (+11)
49 [GO] 2021―Apr―22 Psychological assessment and lived experiences of recovered COVID-19 patients who presented for convalescent plasma donation A. Maheshwari, M. Varshney, K. Gupta, M. Bajpai
50 [GO] 2021―Apr―20 Early and persistent viral clearance in COVID-19 patients treated with convalescent plasma Massimo Franchini, Claudia Glingani, Angela Bellani, Nicola Cicorella, Alessandro Amadini, Giuseppe De Donno, Salvatore Casari
51 [GO] 2021―Apr―19 What has changed after the COVID-19 pandemic in the publication process? A look-back to “Transfusion clinique et biologique” O. Garraud
52 [GO] 2021―Apr―13 Vaccination COVID-19 chez les donneurs de sang indiens: évaluer l'impact sur la période de report Naveen Bansal, Manish Raturi
53 [GO] 2021―Apr―08 Bioethical Perspective of Convalescent Plasma Therapy for COVID-19: A Systematic Review Muhammad Ardi Munir, Pascal Adventra Tandiabang, Tri Setyawati, Amirah Basry, Asep Dwitama Cyio, Nurulhuda Rahman
54 [GO] 2021―Apr―08 What convalescent plasma in treating severe acute respiratory infections of viral aetiology can hint for COVID-19? Evidence from a meta-analysis Jun Zeng, Saifu Yin, Xinmiao Du, Turun Song, Tao Lin
55 [GO] 2021―Mar―06 Constraints And Challenges In Convalescent Plasma Collection Amidst The Covid 19 Pandemic- Strategies And Recommendations To Overcome These Smita Mahapatra, Sanghamitra Pati
56 [GO] 2021―Jan―14 Indian blood donor selection guidelines: Review in the context of the ongoing COVID-19 pandemic Kunal Das, Manish Raturi, Nitika Agrawal, Mansi Kala, Anuradha Kusum
57 [GO] 2020―Dec―05 Emergence of Ancient Convalescent plasma (CP) Therapy: to Manage COVID-19 Pandemic Barsha Dassarma, Satyajit Tripathy, Motlalepula Matsabisa
58 [GO] 2020―Dec―02 Unexpected increase of the compliance rate of transfusion requisition form after the COVID-19 outbreak Liyan Yang, Jing Feng, Yongmei Jiang
59 [GO] 2020―Dec―01 The impact of COVID-19 pandemic on blood supplies and transfusion services in Eastern Mediterranean Region Arwa Z Al Riyami, Yetmgeta E Abdella, Maha A Badawi, Sathiya M Panchatcharam, Yasser Ghaleb, Mahtab Maghsudlu, et al. (+12)
60 [GO] 2020―Nov―06 COVID-19, transfusion, and publishing ethics O. Garraud
61 [GO] 2020―Oct―20 Post-donation information and haemovigilance reporting for COVID-19 in Greece: information supporting the absence of SARS-CoV-2 possible transmission through blood components Constantina Politis, Maria Papadaki, Lida Politi, Georgia Kourti, Clive Richardson, Marina Asariotou, et al. (+2)
62 [GO] 2020―Oct―19 The Impact of COVID-19 on Transfusion-Dependent Thalassemia Patients of Karachi, Pakistan: A Single-Center Experience Shajeea Arshad Ali, Dua Azim, Hafiz Muhammad Hassan, Ayman Iqbal, Naseem Ahmed, Sohail Kumar, Sundus Nasim
63 [GO] 2020―Oct―17 Assessment of blood supply and usage pre- and during COVID-19 pandemic; a lesson from non-voluntary donation Christopher Ogar Ogar, Henshaw Uchechi Okoroiwu, Emmanuel Ifeanyi Obeagu, Joyce Ezekiel Etura, Dennis Akongfe Animye
64 [GO] 2020―Oct―03 Prevention and treatment of COVID-19-associated hypercoagulability: recommendations of the Algerian society of transfusion and hemobiology Chekkal Mohamed, Deba Tahra, Hadjali Soraya, Lamara Hassiba, Oulaa Hanifa, Zouai Karima, Hariti Ghania
65 [GO] 2020―Sep―25 A case of COVID-19 Convalescent Plasma Donation in Greece: directed donation for compassionate use in the donor's critically ill father Glykeria Vlachogianni, Helen Hassapopoulou-Matamis, Constantina Politis, Eirini Fylaki, Andreas Mentis
66 [GO] 2020―Sep―25 ABO blood group system is associated with COVID-19 mortality: An epidemiological investigation in the Indian population Sunali Padhi, Subham Suvankar, Debabrata Dash, Venketesh K. Panda, Abhijit Pati, Jogeswar Panigrahi, Aditya K Panda
67 [GO] 2020―Jul―10 Because Every Drop Counts: Blood Donation During the COVID-19 Pandemic Kamal Kant Sahu, Manish Raturi, Ahmad Daniyal Siddiqui, Jan Cerny
68 [GO] 2020―Jun―12 Plasma from donors convalescent from SARS-CoV-2 infection - A matter of priorities Albert Farrugia
69 [GO] 2020―May―16 Use of convalescent plasma in COVID-19 patients in China Mei Zhu, Hu Kaiming, Zhijun Zhu
70 [GO] 2020―May―07 A quick “Can I donate blood” self-assessment tool amid the COVID-19 outbreak M. Raturi
71 [GO] 2020―Apr―27 The Blood Supply Management amid the COVID-19 Outbreak Manish Raturi, Anuradha Kusum
72 [GO] 2020―Mar―31 The Active Role of a Blood Center in Outpacing the Transfusion Transmission of COVID-19 Manish Raturi
73 [GO] 2020―Mar―31 COVID-19: Is a paradigm change to be expected in health care and transfusion medicine? Olivier Garraud


[de][en]

Last change 2022―Jan―26 16:55:12 UTC

© Daten-Quadrat 2022       Done in 0.010 sec